{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:50:44Z","timestamp":1782384644251,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dmd.2026.100308","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:00:36Z","timestamp":1777474836000},"page":"100308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation"],"prefix":"10.1016","volume":"54","author":[{"given":"Ilona","family":"Wehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Michiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Walser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homam","family":"Tayfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Imaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3678-2976","authenticated-orcid":false,"given":"Daisuke","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Schreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/hsz-2016-0259","article-title":"Expression, regulation and function of intestinal drug transporters: an update","volume":"398","author":"M\u00fcller","year":"2017","journal-title":"Biol Chem"},{"issue":"5","key":"10.1016\/j.dmd.2026.100308_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.apsb.2016.07.012","article-title":"An update on the role of intestinal cytochrome P450 enzymes in drug disposition","volume":"6","author":"Xie","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"2-3","key":"10.1016\/j.dmd.2026.100308_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-409X(97)00039-2","article-title":"Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction","volume":"27","author":"Thummel","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2133\/dmpk.23.87","article-title":"Intestinal first-pass metabolism of CYP3A4 substrates","volume":"23","author":"Kato","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100308_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2009.05.044","article-title":"Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10","volume":"378","author":"Mizuma","year":"2009","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.dmd.2026.100308_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00266354","article-title":"Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance","volume":"42","author":"Edgar","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0009-9236(95)90068-3","article-title":"Interaction between grapefruit juice and midazolam in humans","volume":"58","author":"Kupferschmidt","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/clpt.2008.195","article-title":"Drug-drug interactions mediated through P-glycoprotein: Clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug","volume":"85","author":"Fenner","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0009-9236(99)90048-6","article-title":"Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin","volume":"66","author":"Lilja","year":"1999","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"Greiner","year":"1999","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.dmd.2026.100308_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0090-9556(25)08415-6","article-title":"The nifedipine-rifampin interaction: evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100308_bib12","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1002\/jps.21708","article-title":"The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans","volume":"98","author":"Takahashi","year":"2009","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.dmd.2026.100308_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/dmd.30.1.4","article-title":"Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas","volume":"30","author":"Nakamura","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/dmd.120.000138","article-title":"Characterization of the human intestinal drug transport with ussing chamber system incorporating freshly isolated human jejunum","volume":"49","author":"Michiba","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100308_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sj\u00f6berg","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.dmd.2026.100308_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejps.2012.02.025","article-title":"Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs","volume":"46","author":"Rozehnal","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pharmaceutics16010037","article-title":"Recent advances in the gastrointestinal complex in vitro model for ADME studies","volume":"16","author":"Michiba","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7244","key":"10.1016\/j.dmd.2026.100308_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.dmd.2026.100308_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","article-title":"Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays","volume":"64","author":"VanDussen","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dmd.2026.100308_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtm.2021.05.005","article-title":"Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research","volume":"22","author":"Yamashita","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"10.1016\/j.dmd.2026.100308_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/dmd.121.000796","article-title":"Usefulness of human jejunal spheroid-derived differentiated intestinal epithelial cells for the prediction of intestinal drug absorption in humans","volume":"50","author":"Michiba","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2026.100308_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100075","article-title":"Characterization of intestinal transporters in human ileal spheroid\u2013derived differentiated cells for the prediction of intestinal drug absorption","volume":"53","author":"Michiba","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100308_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106481","article-title":"Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules","volume":"188","author":"Kourula","year":"2023","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-95823-z","article-title":"Robust and reproducible human intestinal organoid-derived monolayer model for analyzing drug absorption","volume":"15","author":"Tanaka","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib26","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001551","article-title":"Human enteroid monolayers: a novel, functionally stable model for investigating oral drug disposition","volume":"53","author":"Arian","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1096\/fba.2023-00132","article-title":"Effect of air-liquid interface on cultured human intestinal epithelial cells","volume":"6","author":"Sabapaty","year":"2023","journal-title":"FASEB Bioadv"},{"key":"10.1016\/j.dmd.2026.100308_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100994","article-title":"Air-liquid interface culture and modified culture medium promote the differentiation of human induced pluripotent stem cells into intestinal epithelial cells","volume":"55","author":"Shirai","year":"2024","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.dmd.2026.100308_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.111.180240","article-title":"In vitro and in vivo P-glycoprotein transport characteristics of rivaroxaban","volume":"338","author":"Gnoth","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.dmd.2026.100308_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100082","article-title":"Investigation of differentiation conditions for canine duodenum, upper jejunum, and ileum crypt-derived cells for drug transport and metabolism","volume":"53","author":"Takezaki","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100308_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.xphs.2015.11.035","article-title":"Application of a human intestinal epithelial cell monolayer to the prediction of oral drug absorption in humans as a superior alternative to the Caco-2 cell monolayer","volume":"105","author":"Takenaka","year":"2016","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100308_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.dmd.2026.100308_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0009-9236(03)00187-5","article-title":"The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity","volume":"74","author":"Gorski","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100308_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.dmd.2026.100308_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clpt.2006.08.014","article-title":"Sex differences in CYP3A activity using intravenous and oral midazolam","volume":"80","author":"Chen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2026.100308_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1124\/dmd.109.031328","article-title":"Sex-dependent differences in cytochrome P450 3A activity as assessed by midazolam disposition in humans: a meta-analysis","volume":"38","author":"Hu","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:24:03Z","timestamp":1782383043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0090955626000772"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100308","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of human intestinal organoid-derived monolayers under air-liquid interface culture for pharmacokinetics evaluation","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100308"}}